Modifiable risk factors remain significant causes of medium term mortality after first time Coronary artery bypass

Babu Kunadian1, Joel Dunning, Russell W J Millner

  • 1Department of Cardiothoracic Surgery, Blackpool Victoria Hospital, UK. Babu.Kunadian@stees.nhs.uk

Insights

Coronary artery bypass grafting (CABG) using cross-clamp fibrillation shows good medium-term survival. Risk factors like diabetes, COPD, obesity, and smoking significantly impact outcomes, necessitating aggressive post-surgery management.

Area of Science:

  • Cardiovascular Surgery
  • Medical Outcomes Research

Background:

  • Limited data exists on medium-term outcomes following Coronary Artery Bypass Grafting (CABG).
  • This study focuses on patients undergoing first-time CABG using cross-clamp fibrillation between 1996 and 2003.

Purpose of the Study:

  • To present outcomes from a single-surgeon series of CABG patients.
  • To identify risk factors associated with medium-term mortality after CABG.

Main Methods:

  • Data collected from Hospital Episode Statistics and departmental systems.
  • Patient outcomes traced using the National Health Service strategic tracing service.
  • Cox-regression analysis applied to identify mortality predictors.

Main Results:

  • Mean follow-up was 5.3 years with complete data.
  • 30-day, 1-year, and 8-year survival rates were 98.4%, 95%, and 79%, respectively.
  • Significant predictors of medium-term mortality included diabetes, COPD, peripheral vascular disease, obesity (BMI>30), and current smoking.

Conclusions:

  • CABG with cross-clamp fibrillation demonstrates low operative mortality and good medium-term survival.
  • Modifiable risk factors such as smoking, COPD, obesity, and diabetes adversely affect survival.
  • Aggressive management of these risk factors post-surgery is crucial for improving long-term outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...